Article
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.
Blood - 1 Aug 2006
Datta Abhik, Bellon Marcia, Sinha-Datta Uma, Bazarbachi Ali, Lepelletier Yves, Canioni Danielle, Waldmann Thomas A, Hermine Olivier, Nicot Christophe
Abstract excerpt
The antiviral thymidine analog azidothymidine (AZT) is used to treat several virus-associated human cancers. However, to date the mechanism of AZT action remains unclear and thus, reasons for treatment failure are unknown. Adult T-cell leukemia/lymphoma (ATL) is an aggressive malignancy of poor prognosis. Here, we report that enduring AZT treatment of T-cell leukemia virus I-infected cells, in vitro and in vivo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
